Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00169663 · ClinicalTrials.gov registry record
Brushite Kidney Stones: A Registry and Database of Clinical and Laboratory Findings
A clinical trial of Nephrolithiasis, sponsored by Indiana Kidney Stone Institute.
- Completed
- Registry status
- 90
- Enrollment target
- 1
- Study location
NCT00169663: Completed study of Nephrolithiasis, sponsored by Indiana Kidney Stone Institute.
NCT00169663 is a study of Nephrolithiasis that has completed, run by Indiana Kidney Stone Institute. The registered enrollment target is 90 participants, below the 119-participant average among 16 other Nephrolithiasis trials with a reported enrollment target (24% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00169663, a study of Nephrolithiasis, has completed, sponsored by Indiana Kidney Stone Institute.
- COMPLETED
- Registry status
- 90 participants
- Enrollment target
- 1
- Study location
Study Summary
Brushite kidney stones are a unique form of calcium phosphate stones that have a tendency to recur quickly if patients are not aggressively treated with stone prevention measures. Little research has been undertaken to better understand the clinical history and potential urinary abnormalities that may predispose one to these troublesome kidney stones.
Conditions Studied
Study Locations (1)
Indiana
- Methodist Hospital - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2003-07 |
| Est. Completion | 2010-11 |
What the finished NCT00169663 record still lists
NCT00169663 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 119-participant average among 16 other Nephrolithiasis trials with a reported enrollment target (24% lower).
The record links to 1 condition, with Nephrolithiasis appearing as the primary indexed condition, and to 0 interventions.
NCT00169663 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT00169663 about?
NCT00169663 is a clinical study titled "Brushite Kidney Stones: A Registry and Database of Clinical and Laboratory Findings". Brushite kidney stones are a unique form of calcium phosphate stones that have a tendency to recur quickly if patients are not aggressively treated with stone prevention measures. Little research has been undertaken to better understand the clinical history and potential urinary abnormalities that m...
What is the current status of trial NCT00169663?
This trial is currently completed. The enrollment target is 90 participants. The study started on 2003-07. Estimated completion is 2010-11.
What conditions does trial NCT00169663 study?
This clinical trial studies the following conditions: Nephrolithiasis.
Who is sponsoring clinical trial NCT00169663?
This trial is sponsored by Indiana Kidney Stone Institute, which has 16 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00169663 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nephrolithiasis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00169663's enrollment target sits among peer trials
90 8th of 16 higher than 9 of 16 other Nephrolithiasis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Nephrolithiasis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Endogenous Oxalate Synthesis in Idiopathic Calcium Oxalate Kidney Stone Disease
RECRUITING · NA
-
Thulium Fiber Laser (TFL) vs Thulio Pulsed Thulium:YAG (p-Tm:YAG)
RECRUITING · NA
-
Methocarbamol vs Oxybutynin for Management of Pain and Discomfort S/P Ureteroscopy Procedure
RECRUITING · NA
-
Gut Oxalate Absorption in Calcium Oxalate Stone Disease
RECRUITING · NA
-
Serum Endotoxin Assay to Predict the Development of Postoperative Infectious Complications and Systemic Inflammatory Response Following Percutaneous Nephrolithotomy.
RECRUITING
-
Evaluation of Genetic Abnormalities Amongst Calcium Phosphate Stone Formers
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia